Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study

Jedd D. Wolchok(Memorial Sloan Kettering Cancer Center), Bart Neyns(Universitair Ziekenhuis Brussel), Gerald P. Linette(Washington University in St. Louis), Sylvie Négrier(Centre Léon Bérard), Jose Lutzky(Mount Sinai Medical Center), L. Thomas(Université Claude Bernard Lyon 1), William Waterfield, Dirk Schadendorf(Essen University Hospital), Michael Smylie, Troy H. Guthrie(Baptist Cancer Center), Jean‐Jacques Grob(Hôpital Sainte-Marguerite), Jason Chesney(University of Louisville), Kevin M. Chin(Bristol-Myers Squibb (Germany)), Kun Chen(Bristol-Myers Squibb (Germany)), Axel Hoos(Bristol-Myers Squibb (Germany)), Steven O’Day(Angeles Clinic and Research Institute), Célèste Lebbé(Université Paris Cité)
The Lancet Oncology
December 9, 2009
Cited by 1,187

Abstract


Related Papers

No related papers found

Powered by citation graph analysis